Kinam Hong
Director/Board Member bij ABIVAX
Profiel
Presently, Kinam Hong is Partner at Sofinnova Partners SAS.
He is also on the board of Abivax SA and LimFlow SA.
In his past career Dr. Hong occupied the position of Portfolio Manager at Exane Asset Management SA and Research Associate at Citigroup Global Markets, Inc. (Broker).
Dr. Hong received a doctorate and an undergraduate degree from the University of Florida and an MBA from INSEAD.
Actieve functies van Kinam Hong
Bedrijven | Functie | Begin |
---|---|---|
ABIVAX | Director/Board Member | - |
Sofinnova Partners SAS
Sofinnova Partners SAS Investment ManagersFinance Sofinnova Partners SA (Sofinnova) is an independent venture capital firm established in 1972 and headquartered in Paris, France. Originally known as Sofinnova, the first venture capital firm created in France, the firm created a U.S. subsidiary in San Francisco in 1976. In 1997, both firms were bought out by their management teams, which become the majority shareholders of the new companies, Sofinnova Partners in Paris and Sofinnova Ventures in San Francisco. | Private Equity Investor | 01-04-2018 |
LimFlow SA
LimFlow SA Medical SpecialtiesHealth Technology LimFlow SA develops and offers medical devices which transformes the treatment of critical limb Ischemi. The firm?s proprietary and CE marked technology is a novel and purely percutaneous therapy for ?no-option? CLI patients. The company was founded by Martin T. Rothman in 2012 and is headquartered in Paris, France. | Director/Board Member | - |
Eerdere bekende functies van Kinam Hong
Bedrijven | Functie | Einde |
---|---|---|
Exane Asset Management SA
Exane Asset Management SA Investment ManagersFinance Exane Asset Management SA (Exane AM) is an alternative investment management firm headquartered in Paris, France. The firm was founded in 2001 and is a subsidiary of Exane SA, itself a subsidiary of BNP Paribas SA (EPA: BNP) in France. Exane AM manages a range of long/short equity market neutral funds designed to respond to the varied needs of a diversified European clientele, composed chiefly of institutional investors, multi-fund managers and private banking professionals. | Analyst-Equity | - |
Citigroup Global Markets, Inc. (Broker)
Citigroup Global Markets, Inc. (Broker) Investment Banks/BrokersFinance Citigroup Global Markets, Inc. (Broker) (CGMI-Broker) is the broker/dealer division of Citigroup Global Markets, Inc., an investment bank headquartered in New York City with additional offices across the US. The firm was founded in 2004 and is a subsidiary of Citigroup Financial Products, Inc., ultimately held by Citigroup, Inc. (NYSE: C). CGMI-Broker covers all market capitalizations of the major global indices and provides macro and quantitative analysis of global markets and sector trends. Their core focus of the group is to help investing clients make informed decisions by providing value-added, independent, insightful analysis. | Analyst-Equity | - |
Opleiding van Kinam Hong
INSEAD | Masters Business Admin |
University of Florida | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
ABIVAX | Health Technology |
Bedrijven in privébezit | 4 |
---|---|
Citigroup Global Markets, Inc. (Broker)
Citigroup Global Markets, Inc. (Broker) Investment Banks/BrokersFinance Citigroup Global Markets, Inc. (Broker) (CGMI-Broker) is the broker/dealer division of Citigroup Global Markets, Inc., an investment bank headquartered in New York City with additional offices across the US. The firm was founded in 2004 and is a subsidiary of Citigroup Financial Products, Inc., ultimately held by Citigroup, Inc. (NYSE: C). CGMI-Broker covers all market capitalizations of the major global indices and provides macro and quantitative analysis of global markets and sector trends. Their core focus of the group is to help investing clients make informed decisions by providing value-added, independent, insightful analysis. | Finance |
Sofinnova Partners SAS
Sofinnova Partners SAS Investment ManagersFinance Sofinnova Partners SA (Sofinnova) is an independent venture capital firm established in 1972 and headquartered in Paris, France. Originally known as Sofinnova, the first venture capital firm created in France, the firm created a U.S. subsidiary in San Francisco in 1976. In 1997, both firms were bought out by their management teams, which become the majority shareholders of the new companies, Sofinnova Partners in Paris and Sofinnova Ventures in San Francisco. | Finance |
Exane Asset Management SA
Exane Asset Management SA Investment ManagersFinance Exane Asset Management SA (Exane AM) is an alternative investment management firm headquartered in Paris, France. The firm was founded in 2001 and is a subsidiary of Exane SA, itself a subsidiary of BNP Paribas SA (EPA: BNP) in France. Exane AM manages a range of long/short equity market neutral funds designed to respond to the varied needs of a diversified European clientele, composed chiefly of institutional investors, multi-fund managers and private banking professionals. | Finance |
LimFlow SA
LimFlow SA Medical SpecialtiesHealth Technology LimFlow SA develops and offers medical devices which transformes the treatment of critical limb Ischemi. The firm?s proprietary and CE marked technology is a novel and purely percutaneous therapy for ?no-option? CLI patients. The company was founded by Martin T. Rothman in 2012 and is headquartered in Paris, France. | Health Technology |